Board Meeting12 Aug 2026, 03:51 pm

Prism Medico Approves Unaudited Standalone Q1 FY27 Results

AI Summary

Prism Medico and Pharmacy Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and a Limited Review Report was issued by Garg Mendiratta & Associates. Mr. Davender Singh, Director, has been authorized to sign the financial statements.

Key Highlights

Board approved unaudited standalone financial results for Q1 FY27.
Results pertain to the quarter ended June 30, 2026.
Financials were reviewed by the Audit Committee.
Auditors issued a Limited Review Report.
Director authorized to sign financial statements.

View BSE Filing

PRISMMEDI

Non Banking Financial Company (NBFC)

PRISM MEDICO AND PHARMACY LTD.

Price Impact